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Abstract
Spatial big data have the “velocity,” “volume,” and “variety” of big data sources and contain addi-
tional geographic information. Digital data sources, such as medical claims, mobile phone call data
records, and geo-tagged tweets, have entered infectious disease epidemiology as novel sources of data
to complement traditional infectious disease surveillance. In this work, we provide examples of how
spatial big data have been used thus far in epidemiological analyses and describe opportunities for
these sources to improve disease mitigation strategies and public health coordination. In addition, we
consider the technical, practical, and ethical challenges with the use of spatial big data in infectious
disease surveillance and inference. Finally, we discuss the implications of the rising use of spatial
big data in epidemiology to health risk communication, and public health policy recommendations
and coordination across scales.
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Introduction
During one of epidemiology’s formative moments, John Snow mapped London households with
cholera and succeeded in highlighting the risk associated with the Broad Street pump. Since then,
spatial investigations have played a critical role in improving our understanding of the associations
between risks and disease outcomes. In infectious disease epidemiology, we ask: Which populations
are at higher risk for disease? Where did this outbreak originate? Where can we expect future
disease outbreaks to arise? —fundamentally, these are spatial questions that rely on spatial data
for answers.
Traditional infectious disease epidemiology is built on the foundation of relatively high quality
and high accuracy data on disease (e.g., serological diagnostics) and behavior (e.g., vaccination sur-
veys). These data are usually characterized by small size, but they benefit from control groups or
designed observational samples from known underlying populations, thus rendering it possible to
make population-level inferences. On the other hand, digital infectious disease epidemiology typi-
cally uses existing digital traces, re-purposing them to identify patterns in health-related processes.
Digital data are electronic in form, and can often be characterized as “big data” when they are
produced in large volumes (i.e. a large number of subjects or a large number of measurements per
subject), with high velocity (i.e. data created in near real-time), and have variety in sources and
organizational structures [1]. When big data are characterized by fine spatial granularity, identifying
point or areal locations, we refer to them here as spatial big data. Big data provide opportunities for
infectious disease epidemiology and public health because they increase accessibility to populations
over space and time; data on personal beliefs, behaviors, and health outcomes are now available
at unprecedented breadth and depth. The trade-off to this tremendous access is the potential for
loss of quality and accuracy. Streams of digital data relevant to public health may serve as proxies
for a desired measure, but these datasets may not meet the assumptions for standard methods of
epidemiological comparison (e.g., self-reported symptoms on social media and serological diagnoses
both serve as proxies for “true cases,” but they have different biases and collection procedures, and
represent different populations).
The trade-off between access and accuracy, and the task of separating true signal from large and
varied noise characterizes the challenge and opportunity of big data for infectious disease epidemi-
ology [2]. In this piece, we focus specifically on spatial big data and its applications to the field of
spatial epidemiology. We highlight the opportunities for spatial big data to improve spatial modeling
and data coverage, and describe ongoing challenges as spatial big data become more pervasive in
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informing disease surveillance, disease control, and public health policy.
Spatial big data open new doors in epidemiology
True to the promise of variety in big data streams, several familiar technologies produce spatial
big data that can be used for infectious disease surveillance and modeling. Social media sites like
Facebook and Twitter allow users to tag individual posts with specific locations, linking geography
to specific health behaviors. Mobile phones send signals with GPS locations and their call data
records are spatially referenced through cell tower locations, both of which enable the measurement
of human activity and mobility [3, 4]. Web search data may capture user location through internet IP
addresses, and online encyclopedia (Wikipedia) access logs may identify locations based on the search
language [5, 6]. Administrative medical claims and pharmacy transactions indicate the location
of healthcare facilities and drugstores where patients seek care and medications [7, 8]. Restaurant
reservation cancellations on sites like OpenTable may provide insight into disease incidence in specific
cities [9].
Infectious disease epidemiology has already witnessed an impact from spatial big data, and the
development of new methodologies and improvements to computational efficiency will only increase
the potential of these data sources. Satellite imaging to infer climate, land use, and population
density information has contributed to a better understanding of the spatial distribution of critical
mosquito disease vectors and the seasonal epidemic dynamics of measles [e.g., 10, 11]. HealthMap,
an automated, online news and outbreak reporting aggregator, has enabled the assimilation of
disparate sources of disease occurrence data and has been used to examine spatial dynamics of
cholera [12]. Mobile phone call data records have provided insights into human mobility that have
informed risk maps, importation potential, and spatial dynamics of dengue and malaria [e.g., 4].
Medical claims data have been used to examine spatial heterogeneity in influenza epidemic timing and
severity [13, 14], while geo-referenced Twitter data has been used to identify spatial anti-vaccination
sentiment [15].
While these studies with spatial big data have leveraged the fine spatial resolution to develop a
detailed understanding of disease risk, there remain untapped opportunities with real-time surveil-
lance, large-scale ecological inference, and adaptive disease mitigation strategies. Harnessing disease
data from digital sources may enable epidemiological analyses to be performed at finer spatial scales
in areas with poor coverage from traditional public health surveillance, and traditional and digital
sources of spatial big data may be combined to account for the bias and gaps in each [e.g., 16]. The
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assimilation of multiple spatial big data sources through flexible statistical modeling methods, and
the continuous nature of data streams could enable near real-time dynamic disease mapping and
risk mapping in the near future. For example, Bayesian statistical approaches have emerged as tools
for merging multi-scale big data sources, incorporating explicit spatial dependencies into maps and
models, and providing a framework for joining disease surveillance data across spatial scales while
explicitly capturing the variation in measurement bias across locations [e.g., 17]. Finally, access to
multiple spatial scales of data allows one scale with missing observations to “borrow information”
from a different scale through the addition of contextual effects in modeling inference [18].
Spatial big data presents technical challenges
While big data offer significant opportunities for epidemiological modeling and analysis, they also
present a variety of technical and practical challenges. The measurement of incomplete and unrep-
resented populations, the lack of consistency and reliability in data over time, and the need for data
and model validation are broad challenges with big data and statistical analysis that are discussed
elsewhere [e.g., 19, 20]. Here, we discuss a narrower set of challenges that arise specifically from the
spatial nature of big data.
Spatial coverage and representation
Spatial big data may provide precise spatial information, but careful users should question the va-
lidity of available data. For one, we know that sources of spatial big data have biases in usership
rates and demographics by location (Figure 1A) [21]. Medical claims record data only from insured
and care-seeking populations, which may vary systematically according to socioeconomic and de-
mographic characteristics. Social media sites where users volunteer spatial data tend to have more
users and higher quality information per capita in urban areas compared to rural ones [21]. Mobile
phone ownership varies by gender and literacy, and phone sharing between multiple individuals and
SIM card switching complicate comparisons of these data across locations [3, 4]. As we cannot often
measure the heterogeneities in user populations, these heterogeneities can translate into poor choices
in sampling design (e.g., how to stratify samples to get a representative population). Beyond het-
erogeneities in user populations, the populations captured by big data (e.g., Twitter users) are not
usually relevant to epidemiology; even if we could generate an unbiased sample of the population,
it may not provide information important to public health. All of these issues complicate analyses
that seek to compare different locations. Ultimately, issues with spatial coverage and representation
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cause problems for statistical inference, which often depend on assumptions of independent random
variation and representative sampling for validity. Future research should compare analyses of spa-
tial big data and analyses of designed observational data in order to demonstrate the validity of
spatial big data samples and to understand which features of a big data sample can produce robust
statistical inference.
Spatial uncertainty and noise
Each source of big data provides a different type of spatial insight, despite their shared feature of
high spatial resolution. Users of social media volunteer their geographical locations in their pro-
files or posts, while internet search engines can log spatial information automatically every time a
web search is performed. Sometimes the data are tied to a static location, as in the case of med-
ical claims and health care facilities, but the cell towers associated with call data records and the
locations of geo-tagged tweets vary dynamically over time (Figure 1B). Across the combinations
of features —self-reported or automated, static or dynamic —among these data sources, there are
additional layers of uncertainty to consider in the context of epidemiology. For one, when spatial
information in big data is not clearly specified, systematic biases in the results may be generated
from the data cleaning process itself (e.g., addresses may be less likely to be geolocated in rural
areas) [e.g., 22]. Second, locations of potential transmission events will often differ from locations
where disease is reported. While these components are explicitly differentiated in medical claims
data (i.e., transmitted in the community, reported at health care facilities), social media posts affil-
iated with dynamic movements could provide undifferentiated information about both transmission
and reporting event locations. Big data provides information at unprecedented levels of spatial
precision, but the spatial information fundamental to infectious disease epidemiology (e.g., location
and conditions that caused a disease transmission event) continues to remain obscured. As big data
becomes more prevalent in epidemiological analysis, public health officials should take care not to
conflate spatial precision with spatial accuracy in statistical inference for disease transmission and
control.
Spatial scales and misalignment
When spatial big data are available at the level of individuals or precise spatial coordinates, practi-
tioners may need to choose the scale of analysis and aggregate data accordingly. Analyzing data at
the individual scale is prone to overfitting and the “atomistic fallacy,” in which we may make incor-
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rect inferences at the group or population-level based on relationships observed in individual-level
data [23]. For example, if we observe an association between body mass index (BMI) and hospital-
ization for influenza among individuals, it may be incorrect to assume that populations with a high
average BMI would have higher rates of influenza-associated hospitalization. On the other hand,
analyzing data at aggregated scales is prone to the “ecological fallacy,” where inferences about indi-
viduals are derived falsely from population-level observations [24, 23]. As an example, if we observed
a negative association between average income and cholera prevalence at a national scale, it would
be erroneous to assume that poor individuals have higher risk of cholera than wealthy individuals.
Similarly, statistical relationships between predictors and disease outcomes may change when anal-
yses are performed at different spatial aggregations. For instance, Google Flu Trends attempted to
estimate influenza activity across different regions of the United States by modeling the relationship
between Google search terms and visits for influenza-like illness (ILI), as reported in traditional
flu surveillance systems [5]. However, the set of search terms identified as “most predictive” of ILI
activity were tuned to specific spatial scales, which means that terms that fit well at the region-level
may not apply to finer resolution data [5, 25]. Additionally, spatial questions often require the use
of multiple data sources, and spatial misalignment arises when data are collected at different spatial
scales and need to be incorporated into a single analysis. For instance, we may seek to understand
the spatial distribution of cases at the state level when data were collected at the parish or county
level (switching between two areal scales), or translate case data associated with household coordi-
nates to cases at the county level (switching between point and areal scales) (Figure 1C). Spatial
big data has expanded the types of spatial information available for data aggregation —posts geo-
tagged on social media might provide information at the level of countries, cities, neighborhoods,
landmarks, and latitude-longitude coordinates —potentially engaging statistical change of support
problems, even for one individual in a single day [24]. The multiplicity of highly resolved spatial
scales also poses concerns for standard data checks, since traditional public health data will not
necessarily be available at scales appropriate for validating comparisons to spatial big data [7, 16].
Finally, choices about how to deal with spatial misalignment have consequences for modeling results.
For instance, recent studies have asked whether Zika virus-associated microcephaly was occurring at
unusually high rates in different Brazilian states. Birth rate data might be collected at one spatial
scale according to regular demographic surveys, but data systems tracking microcephalic live births
would likely have finer spatial detail. Depending on the choice of spatial scale, the combination of
these two data sources creates the potential for both over and under estimation of microcephaly
rates.
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Spatial confidentiality and ethics
The practice of collecting data without seeking appropriate ethical approval presents some risk for
digital infectious disease epidemiology, and the access to fine-grain spatial information further deep-
ens this concern. Safeguards currently implemented for collecting and sharing spatial big data have
focused on the obfuscation and aggregation of shared data to protect privacy, and the anonymiza-
tion and de-identification of individuals. Many research institutions have standardized practices to
protect individual privacy that follow the guidance of institutional review boards (IRBs), disclo-
sure review boards for public use data, and federal laws (e.g., the Health Insurance Portability and
Accountability Act of 1996 (HIPAA) in the United States), but these organizations do not often
recognize high resolution spatial data as a source that should be covered under human subjects pro-
tection policies [26]. Several studies have provided examples where seemingly anonymized data could
be mined (or linked with other databases) for de-anonymization: de Montjoye et al. [27] showed
that four spatio-temporal position points from mobile phone records can be sufficient to uniquely
identify 95% of individuals in a large de-identified dataset; and Homer et al. [28] showed that the
sheer quantity of data collected could be sufficient to re-identify individuals in a genetic database.
These issues already push the limits of existing ethical review mechanisms and our understanding
of de-anonymization. In the future, guidelines to protect privacy and confidentiality may require:
the masking of individual-level records through the aggregation of data to coarser spatial resolutions
(Figure 1D), the provision of synthetic datasets that attempt to mimic underlying distributions [29],
or the distillation of spatial big data to parameters commonly used in epidemiological models. In-
vestigations may consider the optimal choice of spatial scale in the context of trade-offs between the
accurate representation of process heterogeneity and the protection of privacy [26] and the improve-
ment of computational efficiency [30]. Nevertheless, public data become increasingly vulnerable to
breaches of privacy as additional data are released and data mining techniques improve over time.
Implications for public health communication and policy
The promise of high spatial and temporal resolutions in spatial big data opens opportunities for
change in the standard practice of public health. In circumstances where adjacent or subordinate
administrative units issue separate public health recommendations (e.g., United States federal, state,
and local governments may issue independent flu vaccination recommendations), spatial big data
may enable these entities to derive their policies from analyses of a common dataset and encour-
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age coordination of preparedness activities across scales [e.g., 14]. There is a growing panoply of
adaptive, behavioral, and health economic modeling methods aimed at identifying the most effective
interventions for human and livestock diseases. As these methods begin to find use during ongoing
outbreaks, the combination of spatial big data and adaptive models could enable the real-time adap-
tive management of infectious diseases and the coordination of disease control efforts across spatial
scales.
In the long term, some sources of big data may become more readily available at finer spatial
resolutions than the administrative regions at which policy decisions are made, even to the level of
the individual. Spatial big data has already changed consumer marketing strategies; rather than
targeting geographic areas with certain socioeconomic and behavioral characteristics, marketers can
now target individual users based on the behaviors demonstrated in their digital traces [31]. Should
epidemiological modeling and design reflect these cultural changes to public health data? Perhaps
an analogous scenario would see individual epidemiological data being used to inform optimal inter-
vention strategies, ignoring the administrative boundaries that typically constrain decision making.
It is difficult to imagine how such a public health infrastructure could operate —resources must
still be coordinated and expended by administrative units, and policy decisions must still apply to
populations (rather than individuals) to maintain feasibility. Nevertheless, epidemiological analy-
ses with spatial big data expand the possibilities for multi-scale coordination of infectious disease
surveillance, response, and forecasting.
The real-time high volume nature of spatial big data makes more epidemiological information
readily available to policymakers, but it also creates challenges for the communication of public
health information. Spatial big data enables small area analyses, which are simultaneously highly
precise to spatial locations and highly uncertain in modeling results about risk of disease. Similarly,
the rise of epidemic forecasting technologies based on spatial big data might present predictions
about risk and epidemic outcomes in precise locations even though the forecasts themselves are
subject to uncertainty [16]. Consumers of analyses derived from spatial big data —clinicians, public
health officials, epidemiologists, modelers —should develop conscientious practices for communicat-
ing uncertainty about spatial results to the public.
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Figure 1: A) Spatial big data have spatial biases in the populations they represent. For instance, as
reported by the 2013 American Community Survey, there is spatial variation in home internet access
across the United States, which might affect the populations generating search query data in Google
Trends. B) With static spatial data (depicted left), individuals (represented with different colors)
report case events (points) at fixed locations. For instance, the two individuals each visited the
same doctor’s office with symptoms multiple times (points along the ‘time’ axis), so their events are
recorded at the same position along the ‘space’ axis (see overlapping trajectories in the lower part
of the ‘space’ axis), while the teal individual visited a different doctor’s office with symptoms three
times in a similar time period. Events from the same individual are connected with a dashed line.
With dynamic spatial data (depicted right), events are recorded as individuals move through space.
For example, the dark blue individual (see trajectory that begins earliest on the ‘time’ axis) recorded
four events when they tweeted about symptoms at work, at the grocery store, at the pharmacy, and
at home, so their case events occur at four different positions along the ‘space axis. Events occur in
time dynamically (as show in this figure), but events may also be aggregated to regular time intervals
(e.g., weekly). C) Data at different spatial scales may have different magnitudes and variability in
time after adjusting for population size, even if they are derived from the same data source. For
instance, we observe time-varying fluctuations and variation in epidemic peak timing and magnitude
in the county-level disease data (grey) that are lost in the state-level data (black). D) One possible
method to protect privacy is to mask individual-level data by aggregating collected data to larger
spatial resolutions. In reality, individuals (black circles) may be connected to other individuals
through mobile phone calls (black lines). The publicly released data may be aggregated to the
level of neighborhoods (green circles), and the number of calls between individuals from different
neighborhoods (green lines) would be represented with different weights (here, depicted with varying
thickness according to number of individual calls).
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